The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
WASHINGTON — Budweiser is returning to the Super Bowl advertising space with a heartwarming commercial featuring its signature Clydesdale horses. The commercial, which was unveiled just two ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
Influencer and software developer, Masheane Sefuthi, has left fans stunned after he admitted having bleached his skin using an unconventional method. The Youtuber, who goes by Mashie online ...
Two of the biggest sports figures in Indianapolis have teamed up in a new commercial for Ascension St. Vincent Hospital. In the 30-second commercial, former NFL quarterback Peyton Manning and ...
Does David Beckham have a secret sibling? In a lighthearted trailer for Stella Artois’ forthcoming Super Bowl 2025 commercial, the soccer legend, 49, and his parents (played by actors ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...